LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · IEX Real-Time Price · USD
17.54
-0.15 (-0.85%)
Jul 2, 2024, 4:00 PM EDT - Market closed
LENZ Therapeutics Market Cap
LENZ Therapeutics has a market cap or net worth of $447.88 million as of July 2, 2024. Its market cap has increased by 189.70% in one year.
Market Cap
447.88M
Enterprise Value
234.64M
1-Year Change
189.70%
Ranking
Category
Stock Price
$17.54
Market Cap Chart
Since the IPO on June 25, 2021, LENZ Therapeutics's market cap has decreased from $951.31M to $447.88M, a decrease of -52.92%. That is a compound annual growth rate of -22.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 451.70M | 197.17% |
| Dec 29, 2023 | 152.00M | -21.28% |
| Dec 30, 2022 | 193.10M | -73.25% |
| Dec 31, 2021 | 721.90M | -24.12% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRAIL, Inc. Common Stock When Issued | 465.26M |
| Community Health Systems | 461.37M |
| biote | 459.07M |
| Taysha Gene Therapies | 455.12M |
| Avid Bioservices | 451.98M |
| Terns Pharmaceuticals | 443.04M |
| Enhabit | 438.87M |
| OmniAb | 438.05M |